Arena begins ADVISE clinical trial for etrasimod in atopic dermatitis

Arena Pharmaceuticals has dosed the first subject in the phase 2 ADVISE clinical trial, which is evaluating etrasimod for the treatment of moderate-to-severe atopic dermatitis ... Read More